Successful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol

dc.contributor.authorTrauth, Janina
dc.contributor.authorSchuler, Rahel
dc.contributor.authorWaitz, Markus
dc.contributor.authorEhrhardt, Harald
dc.contributor.authorFritzenwanker, Moritz
dc.contributor.authorHerold, Susanne
dc.date.accessioned2025-03-19T14:06:48Z
dc.date.available2025-03-19T14:06:48Z
dc.date.issued2024
dc.description.abstractCefiderocol is a new siderophore-beta-lactam antibiotic used for the treatment of severe multidrug-resistant infections like sepsis, hospital-acquired and ventilator-associated pneumonia in adults, but there are only single reports on its use in the neonatal population. We describe the successful cefiderocol treatment of a newborn with pneumogenic sepsis due to Stenotrophomonas maltophilia.en
dc.identifier.urihttps://jlupub.ub.uni-giessen.de/handle/jlupub/20340
dc.identifier.urihttps://doi.org/10.22029/jlupub-19691
dc.language.isoen
dc.rightsNamensnennung 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.ddcddc:610
dc.titleSuccessful therapy of a newborn with Stenotrophomonas maltophilia nosocomial pneumonia with cefiderocol
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.journaltitleInfection
local.source.urihttps://doi.org/10.1007/s15010-024-02404-9

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Lade...
Vorschaubild
Name:
10.1007_s15010-024-02404-9.pdf
Größe:
816.31 KB
Format:
Adobe Portable Document Format